If we do a little calculation based on the initial receipt from Lloyds pharma of $1,200,000 for the first order of viraleze and base that number on the population in UK, we can then compare the potential of the stock/sales required in India................... The mind boggles with the opportunity we are currently sitting on here!
We just need SPL to do some deals!
